Azenta Inc (AZTA)
42.62
-1.88
(-4.24%)
USD |
NASDAQ |
Nov 14, 16:00
42.00
-0.62
(-1.47%)
Pre-Market: 08:51
Azenta Cash from Investing (Quarterly): 201.62M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 201.62M |
| March 31, 2024 | -270.61M |
| December 31, 2023 | 98.40M |
| September 30, 2023 | 102.49M |
| June 30, 2023 | 214.37M |
| March 31, 2023 | 58.17M |
| December 31, 2022 | 56.36M |
| September 30, 2022 | -374.48M |
| June 30, 2022 | 31.87M |
| March 31, 2022 | 1.827B |
| December 31, 2021 | -18.42M |
| September 30, 2021 | -17.52M |
| June 30, 2021 | -101.45M |
| March 31, 2021 | 2.909M |
| December 31, 2020 | -30.29M |
| September 30, 2020 | -10.19M |
| June 30, 2020 | -8.515M |
| March 31, 2020 | -17.27M |
| December 31, 2019 | 13.23M |
| September 30, 2019 | 619.39M |
| June 30, 2019 | -5.872M |
| March 31, 2019 | -3.61M |
| December 31, 2018 | -398.60M |
| September 30, 2018 | -6.509M |
| June 30, 2018 | -22.04M |
| Date | Value |
|---|---|
| March 31, 2018 | -25.57M |
| December 31, 2017 | -94.35M |
| September 30, 2017 | -45.20M |
| June 30, 2017 | 1.676M |
| March 31, 2017 | -1.385M |
| December 31, 2016 | -9.284M |
| September 30, 2016 | -0.458M |
| June 30, 2016 | -4.325M |
| March 31, 2016 | -0.779M |
| December 31, 2015 | -5.312M |
| September 30, 2015 | -4.965M |
| June 30, 2015 | -3.66M |
| March 31, 2015 | 0.56M |
| December 31, 2014 | -9.572M |
| September 30, 2014 | -23.57M |
| June 30, 2014 | 29.30M |
| March 31, 2014 | -15.20M |
| December 31, 2013 | -8.325M |
| September 30, 2013 | -1.233M |
| June 30, 2013 | -5.297M |
| March 31, 2013 | -0.713M |
| December 31, 2012 | 0.094M |
| September 30, 2012 | -6.681M |
| June 30, 2012 | -24.60M |
| March 31, 2012 | 19.63M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-374.48M
Minimum
Sep 2022
1.827B
Maximum
Mar 2022
92.49M
Average
2.909M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -67.60M |
| Harvard Bioscience Inc | -1.111M |
| Bionano Genomics Inc | 28.63M |
| Akoya Biosciences Inc | 9.054M |
| Singular Genomics Systems Inc | 23.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.791M |
| Cash from Financing (Quarterly) | -224.44M |
| Free Cash Flow | 40.93M |
| Free Cash Flow Per Share (Quarterly) | -0.0907 |
| Free Cash Flow to Equity (Quarterly) | -4.802M |
| Free Cash Flow to Firm (Quarterly) | -4.802M |
| Free Cash Flow Yield | 1.71% |